rewrite this title Cubs Backed Out Of Luzardo Trade After Medical Review

The Cubs pulled out of an offseason trade agreement with the Marlins that would have sent Jesús Luzardo to Chicago after a review of the lefty’s medical records, reports Ken Rosenthal of The Athletic. Luzardo spent time on the injured list last season with both elbow inflammation and a lumbar stress reaction in his back; the latter injury kept him from pitching after late June. Specifics on the return that the Cubs would have sent to Miami remain unreported.

It stands to reason the trade would have occurred in the middle of December. Rosenthal writes that the Luzardo talks took place after the team’s two-year agreement with Matthew Boyd on December 2. USA Today’s Bob Nightengale reported on December 14 that the Cubs had shown interest in Luzardo. Bruce Levine of 670 The Score reported two days later that the Cubs were pushing to get a deal done. By December 19, Levine had reported that talks were essentially dead.

Miami pivoted quickly, trading Luzardo to the Phillies on December 22. Philadelphia sent prospects Starlyn Caba and Emaarion Boyd to their division rivals while also acquiring minor league catcher Paul McIntosh. The Cubs aimed lower in their rotation pursuit. They signed swingman Colin Rea to a one-year, $5MM deal in January. Rea began the season as the sixth starter but has drawn into the rotation after Chicago lost Justin Steele to season-ending UCL surgery.

In his first session with Philadelphia media around the New Year, Luzardo said he’d “felt 100% the whole offseason.” He noted that the back injury had impacted him for most of the ’24 season before becoming something through which he could no longer pitch. He said in December that he felt it was “all figured out” and “back to normal.”

The Phillies were clearly comfortable with their review. It’s not unheard of for teams to have differing evaluations on a player’s medicals. The Yankees pulled out of a Jack Flaherty deadline deal before he was traded to the Dodgers last summer. The Braves and Orioles each backed out of free agent agreements with Jeff Hoffman prior to his three-year deal with the Blue Jays. They’re not completely analogous — free agent signees go through a physical examination, while teams usually just review the medical records of their trade targets — but this isn’t unique.

Luzardo has gotten out to a fantastic start with the Phils. He’s averaging just over six innings per appearance and owns a 2.08 earned run average through 30 1/3 frames. He has fanned 30% of opponents while averaging 96.4 MPH on his fastball — a tick above last season’s 95.2 mark. None of that guarantees that he’ll stay healthy, of course, but the Phillies are surely pleased with the early returns.

The southpaw will take the ball at Wrigley Field tomorrow opposite Ben Brown in the second game of a weekend set. He’s making $6.225MM this season and will likely earn something in the $10-12MM range for his final arbitration trip in 2026. Luzardo will hit free agency in advance of his age-29 campaign two years from now.